In addition, the oncogenic mutations of the splicing factor U2AF35 in MDS result in the abnormal processing of ATG7 pre-mRNA and decreasing ATG7 level, thereby contributing to the progression of AML [72]. Here, U2AF1 is linked to myelodysplastic syndrome.